JP2022550641A5 - - Google Patents

Info

Publication number
JP2022550641A5
JP2022550641A5 JP2022546588A JP2022546588A JP2022550641A5 JP 2022550641 A5 JP2022550641 A5 JP 2022550641A5 JP 2022546588 A JP2022546588 A JP 2022546588A JP 2022546588 A JP2022546588 A JP 2022546588A JP 2022550641 A5 JP2022550641 A5 JP 2022550641A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
compound according
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022546588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550641A (ja
JP7780439B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054348 external-priority patent/WO2021071803A1/en
Publication of JP2022550641A publication Critical patent/JP2022550641A/ja
Publication of JP2022550641A5 publication Critical patent/JP2022550641A5/ja
Application granted granted Critical
Publication of JP7780439B2 publication Critical patent/JP7780439B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022546588A 2019-10-07 2020-10-06 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素二環式化合物 Active JP7780439B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962911642P 2019-10-07 2019-10-07
US62/911,642 2019-10-07
PCT/US2020/054348 WO2021071803A1 (en) 2019-10-07 2020-10-06 Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers

Publications (3)

Publication Number Publication Date
JP2022550641A JP2022550641A (ja) 2022-12-02
JP2022550641A5 true JP2022550641A5 (https=) 2024-05-23
JP7780439B2 JP7780439B2 (ja) 2025-12-04

Family

ID=75436850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022546588A Active JP7780439B2 (ja) 2019-10-07 2020-10-06 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素二環式化合物

Country Status (11)

Country Link
US (1) US20230040182A1 (https=)
EP (1) EP4041408A4 (https=)
JP (1) JP7780439B2 (https=)
KR (1) KR20220079575A (https=)
CN (1) CN114728177B (https=)
AU (1) AU2020363354A1 (https=)
BR (1) BR112022006250A2 (https=)
CA (1) CA3156981C (https=)
IL (1) IL291867A (https=)
MX (1) MX2022004144A (https=)
WO (1) WO2021071803A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023003841A (es) 2020-10-06 2023-06-23 De Shaw Res Llc Compuestos lactámicos como bloqueadores del canal agitador de potasio kv1.3.
CN114437070A (zh) * 2022-01-19 2022-05-06 广西-东盟食品检验检测中心 一种他达拉非新型衍生物的制备方法
WO2024088343A1 (zh) * 2022-10-28 2024-05-02 上海深势唯思科技有限责任公司 一种芳基杂环类Kv1.3抑制剂及其制备方法和用途
TW202521512A (zh) 2023-07-31 2025-06-01 美商美國禮來大藥廠 Kv1.3鉀shaker通道阻斷劑之固體形式及其使用方法
WO2026021011A1 (zh) * 2024-07-26 2026-01-29 浙江海正药业股份有限公司 芳基三环类衍生物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007052A1 (en) * 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
US6939968B2 (en) * 2002-12-23 2005-09-06 Bristol-Myers Squibb Company Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
WO2005030729A1 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Isoquinoline potassium channel inhibitors
CN100530013C (zh) * 2005-03-04 2009-08-19 松下电器产业株式会社 电子设备控制装置及其控制方法
US7538110B2 (en) * 2005-10-27 2009-05-26 Adolor Corporation Opioid antagonists
US8124636B2 (en) * 2008-04-30 2012-02-28 Hoffmann-La Roche Inc. Imidazolidinone derivatives as 11B-HSD1 inhibitors
TW201026708A (en) * 2008-12-12 2010-07-16 Solvay Pharm Bv Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers
WO2011073273A1 (en) * 2009-12-16 2011-06-23 Evotec Ag Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators
US20120065210A1 (en) * 2010-09-15 2012-03-15 Xin-Jie Chu Substituted hexahydropyrrolo[1,2-c]imidazolones
TWI698438B (zh) * 2015-03-13 2020-07-11 德商4Sc製藥公司 Kv1.3抑制劑及其醫學應用

Similar Documents

Publication Publication Date Title
JP2022550641A5 (https=)
JP2022550640A5 (https=)
JP2022552445A5 (https=)
JP2022551197A5 (https=)
JP2019514883A5 (https=)
TWI749934B (zh) 製備2-氟-4-甲基-5-(4-環丙基-1h-咪唑-1-基)苯甲酸之方法
JP2024167182A5 (https=)
JP2019514876A5 (https=)
JP2023518286A5 (https=)
JP2021523221A5 (https=)
JP2025504486A5 (https=)
JP2009500347A5 (https=)
JP2021120411A5 (https=)
JP2019514882A5 (https=)
JP2021523200A5 (https=)
RU2018127360A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2007524696A5 (https=)
JP2018522925A5 (https=)
JP2010519204A5 (https=)
JP2021522262A5 (https=)
CN115605479A (zh) 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用
JP2024510274A5 (https=)
EA034015B1 (ru) Модуляторы р2х7
JP2025509697A5 (https=)
JP2022529311A5 (https=)